KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

Impact of RSV Prevention in Infancy on Prevalence of Asthma Among 9-14-Year-old Native American Children in the Southwest United States.

Rachel M Hartman, Jessica E Atwell, Carol Tso, Ladonna Becenti, Laura B Brown, Ruth A Karron, Kamellia Kellywood, Samantha Martin, Katherine L O'Brien, Robert C Weatherholtz, Laura L Hammitt

Pediatr Infect Dis J 44(9) 821-825

PMID40208934
PMCID-
DOI10.1097/INF.0000000000004818
发表日期2025-04-10
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

BACKGROUND: The impact of respiratory syncytial virus (RSV) prevention on persistent childhood asthma is unknown. We revisited Native American children 9-14 years old who participated as infants in a phase III, randomized, placebo-controlled trial of an efficacious monoclonal antibody (motavizumab) for prevention of RSV to quantify asthma prevalence and investigate relationships between RSV prevention and subsequent asthma. METHODS: Families that participated in the phase III RSV prevention trial were contacted. Following informed consent, data were collected by parental questionnaire and medical record review to assess respiratory health. Composite outcomes for asthma were defined using a combination of questionnaire and chart review data. Relative risk reductions (RRRs) for asthma-related outcomes were stratified by motavizumab and placebo recipients. RESULTS: Of the 2127 original trial participants, 97% were eligible for enrollment in this follow-up study, of which 1773 (86%) were enrolled at a median age of 11 years (range: 9-14). The composite measure of asthma prevalence was 18.2% (95% confidence interval: 16.5, 20). The point estimate for persistent asthma was lower in motavizumab recipients [17.5% (15.4, 19.7)] compared with placebo recipients [19.7% (16.6, 23.1)], but this difference was not statistically significant [RRR: 11.1% (-9.1, 27.6)]. CONCLUSIONS: Asthma-related outcomes occurred less frequently among children who received motavizumab compared with placebo in infancy; however, these findings were not statistically significant, related to insufficient study power. The potential for reduction in asthma related to the prevention of RSV should be further evaluated in larger studies, especially given the elevated asthma prevalence observed in Native American children in this study.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。